-
Mount Sinai and Rumi Scientific Team Up to Advance Drug Discovery for Rare Genetic Disorders Tied to Autism
January 6, 2021
The Seaver Autism Center and Rumi Scientific initiate a pipeline to create high-throughput screening platforms to efficiently test thousands of therapeutic compounds for rare disorders with high risk of autism – starting with ADNP, DDX3X, and FOXP1 genes. -
Epigenetic Changes in ADNP Syndrome, a Cause of Autism, Do Not Indicate Profound Presentation of the Disorder
August 5, 2020
Study Finds Epigenetic Signatures Show Little Correlation to Severity of Symptoms -
Seaver Autism Center For Research and Treatment at Mount Sinai Launches First Drug Trial for ADNP Syndrome
July 7, 2020
Ketamine may provide hope for families affected by a rare disorder that is a leading genetic cause of autism -
Mount Sinai to Accelerate Rare Disease Research Through a Grant from the Chan Zuckerberg Initiative
February 10, 2020
Grant supports parent-led DDX3X Foundation that selected the team at Seaver Autism Center as research and clinical partners -
Largest Autism Sequencing Study to Date Identifies 102 Genes Associated With the Condition
January 23, 2020
For this study, an international team of researchers from more than 50 sites collected and analyzed more than 35,000 participant samples, including nearly 12,000 with ASD, the largest autism sequencing cohort to date. -
Meta-Analysis Highlights Important Challenges In Cognitive Processing For Adults With Autism Spectrum Disorder Without Overall Intellectual Disability
January 2, 2019
Seaver Autism Center study results contribute to understanding of patterns of cognitive functioning in adults with autism and highlight the importance of a broader approach when studying cognition. -
Four Studies by Mount Sinai Investigators Featured in Special Issue of Science Focused on Big Data
December 13, 2018
Genome-wide de novo risk score implicates promoter variation in autism spectrum disorder Joseph D. Buxbaum, PhD, Director of the Seaver Autism Center for Research and Treatment and Professor of Psychiatry, Neuroscience, and Genetics and Genomic Sciences. - Common Medications Taken During Pregnancy Are Not Associated With Risk for Autism
October 31, 2018
Babies exposed in the womb to the majority of medications that target neurotransmitter systems, including typical targets of antidepressants and antipsychotic drugs, are not any more likely to develop autism than non-exposed babies. - Mount Sinai Studies Selected as Top Research Advances of 2017 by Federal Advisory Committee on Autism
July 5, 2018
Five publications from The Seaver Autism Center for Research and Treatment at Mount Sinai were nominated as important advances in autism spectrum disorder (ASD) research by the Interagency Autism Coordinating Committee (IACC), a federal advisory committee that coordinates all ASD efforts within the Department of Health and Human Services concerning ASD, for their annual Summary of Advances report.
- The Seaver Autism Center for Research and Treatment at Mount Sinai Announces Clinical Trial of New Investigational Therapy for Phelan-McDermid Syndrome
May 7, 2018
The Seaver Autism Center for Research and Treatment at Mount Sinai announced today the start of patient enrollment in a new interventional study of an investigational therapy in the treatment of epilepsy associated with Phelan-McDermid syndrome.
- Mount Sinai of New York and Els for Autism Foundation Join Forces to Establish Research Institute at The Els Center of Excellence in Jupiter, Florida
April 2, 2018
The newly created Seaver Els Institute will bring together personalized education, clinical research and scientific investigation for individuals and families who are affected by autism spectrum disorder.
- The Seaver Center for Autism Research and Treatment Receives $2.78 Million Gift from the Beatrice and Samuel Seaver Foundation to Support Precision Medicine Research in Autism Spectrum Disorders
March 5, 2018
Trustees Hirschell E. Levine and John Cohen of the Beatrice and Samuel Seaver Foundation recently announced a $2.78 million gift to The Seaver Autism Center for Research and Treatment at Mount Sinai to support precision medicine research in autism spectrum disorders (ASD), including rare genetic causes of autism.
- Mount Sinai Study to Characterize Rare Neurodevelopmental Disorder Tied to Autism
December 12, 2017
Researchers seek to transform understanding of and inform precision treatment approaches to newly identified syndrome.
- Large study shines spotlight on 'mosaic' mutations in autism (Spectrum News)
July 19, 2017
New findings published in Nature Neuroscience add to mounting evidence that mosaic mutations contribute to autism risk.
- The social ties between autism and schizophrenia (Spectrum News)
July 12, 2017
Autism and schizophrenia share a long and tangled history. Comparing the social features of the two conditions could lead to better treatments and a deeper understanding of each.
- New Research Suggests Older Dads Have “Geekier” Sons
June 20, 2017
Mount Sinai study suggests that this gives them certain advantages over their peers.
- Autism Risk: Why Are More Girls Protected From Diagnosis? (Newsweek)
June 10, 2017
The Autism Sisters Project aims to understand protective factors for autism by studying sisters of individuals with autism.
- Exposure to Specific Toxins and Nutrients During Late Pregnancy and Early Life Correlated with Autism Risk
June 1, 2017
Mount Sinai study uses a unique source - baby teeth - to reveal that both the timing and amount of exposure can affect diagnosis.
- Paternal Age at Conception May Influence Social Development in Offspring (Elselvier)
May 1, 2017
Children of very young and older fathers show distinct patterns of learning social skills.
- What you think you know about autism might be a lie (Metro)
April 17, 2017
Dr. Buxbaum answers questions about autism diagnosis, causes and misconceptions.
- Mount Sinai Researchers Receive Major NIH Award for Autism Genetics Research
April 3, 2017
$7 million grant extends the Autism Sequencing Consortium through 2022 to collect genetic data of more than 50,000 individuals.
- How Rats Could Lead to Autism Drugs That Actually Work (The Atlantic)
March 16, 2017
Dr. Harony-Nicolas, Instructor at the Seaver Center, discusses her work with genetically modified rats.
- All in the Family: New Research Explains How Family Members Can Impact an Autism Diagnosis
March 15, 2016
Children who have older siblings or frequent interactions with grandparents are diagnosed with ASD earlier than those who do not, Seaver researchers reported in the journal Autism
- Couple with Asperger's syndrome: 'We're even more extraordinary together' (CNN)
February 24, 2017
Seaver Chief Psychologist Dr. Paige Siper discusses social interaction and communication in autism and Asperger's.
- Mount Sinai Researchers Generate First In-Depth Characterization of a Genetically Modified Rat Model for Autism and Intellectual Disability
January 30, 2017
Researchers at the Seaver Autism Center have generated and characterized a genetically modified rat model of autism and intellectual disability, which provides important leads into how Shank3 plays a role in synapse development and behavior.
- Silencing Select Brain Cells Triggers Social Deficits in Mice(Spectrum News)
November 12, 2016
Dr. Morishita investigates the link between cellular deficits and social behaviors in mice at the 2016 Society for Neuroscience Annual Meeting in San Diego. - Girls & autism: It can be subtle, or absent, for some at risk(Associated Press)
October 25, 2016
The Autism Sisters Project seeks to understand gender-based differences in autism in order to identify possible genetic clues and protective factors.
- New Treatments for Phelan-McDermid Syndrome: A Family's Story (Mount Sinai Science & Medicine Magazine)
September 28, 2016
The Buchanan family moved from Utah to New York so their son with Phelan-McDermid Syndrome could participate in treatment trials at the Seaver Autism Center. - Where Are All the Girls with Autism? (Autism Science Foundation Podcast)
September 26, 2016
Hear what you missed if you were unable to attend the Seaver Autism Center Annual Advances in Autism Conference on September 25th!
- NY1 City HealthBeat with Dr. Kolevzon (NY1)
April 30, 2016
Dr. Kolevzon, Clinical Director of the Seaver Autism Center, talks about the latest developments in autism research and treatment for National Autism Awareness Month. - Hillary Clinton's Plan to Support Children, Youth and Adults Living with Autism and their Families (HillaryClinton.com)
January 5, 2016
Hillary Clinton's plan to support autism research and services highlights the work of the Autism Sequencing Consortium, founded and led by Dr. Buxbaum. - Joseph D Buxbaum PhD Elected to National Academy of Medicine
October 19, 2015
Dr. Buxbaum, Director of the Seaver Autism Center, is one of 70 new members of the prestigous National Academy of Medicine. - What Really Causes Autism (Scientific American Mind)
October 15, 2015
The mystery is largely solved: autism is primarily a genetic disorder but a complex one that is slowly yielding its secrets.
- Growth Hormone Treatment Improves Social Impairments in Patients with Genetic Disorder Known to Cause Autism
February 18, 2015
A growth hormone can significantly improve the social impairment associated with autism spectrum disorder (ASD) in patients with a related genetic syndrome. - Changes in Scores of Genes Contribute to Autism Risk
October 29, 2014
Newfound genetic differences provide many hints at causes. - Common Gene Variants Account for Most of the Genetic Risk for Autism
July 21, 2014
Heritability trumps spontaneous glitches, environment. - Icahn School of Medicine at Mount Sinai Joins Autism BrainNet Tissue Bank
May 29, 2014
Consortium of premiere research institutions will provide critically needed brain tissue for autism research.
- Genetic and Environmental Influences are Equally Important Risk Factors for Autism Spectrum Disorder
Mary 5, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai.
- Mount Sinai Researchers Identify Genetic Alterations in Shared Biological Pathways as Major Risk Factor for Autism Spectrum Disorder
April 24, 2014
A substantial proportion of risk for developing autism spectrum disorders (ASD), resides in genes that are part of specific, interconnected biological pathways, according to researchers from the Icahn School of Medicine at Mount Sinai.